CH545296A - 4-amino-6,7,8-trimethoxyquinazolines - Google Patents
4-amino-6,7,8-trimethoxyquinazolinesInfo
- Publication number
- CH545296A CH545296A CH1519573A CH1519573A CH545296A CH 545296 A CH545296 A CH 545296A CH 1519573 A CH1519573 A CH 1519573A CH 1519573 A CH1519573 A CH 1519573A CH 545296 A CH545296 A CH 545296A
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- compounds
- amino
- formamide
- known per
- Prior art date
Links
- QYUJUMGMWSGPJJ-UHFFFAOYSA-N 6,7,8-trimethoxyquinazolin-4-amine Chemical class N1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1N QYUJUMGMWSGPJJ-UHFFFAOYSA-N 0.000 title abstract 2
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- ORRMRZIJVLFOOZ-UHFFFAOYSA-N 6,7,8-trimethoxy-1h-quinazolin-4-one Chemical compound COC1=C(OC)C(OC)=CC2=C1NC=NC2=O ORRMRZIJVLFOOZ-UHFFFAOYSA-N 0.000 claims description 4
- CDLRORXPBBREER-UHFFFAOYSA-N COCC(C(COC)=C1COC)=CC(C(O)=O)=C1N Chemical compound COCC(C(COC)=C1COC)=CC(C(O)=O)=C1N CDLRORXPBBREER-UHFFFAOYSA-N 0.000 claims description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 239000005457 ice water Substances 0.000 claims description 2
- 239000000543 intermediate Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 229910004679 ONO2 Inorganic materials 0.000 abstract 1
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- 230000000916 dilatatory effect Effects 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
Abstract
4-Amino-6,7,8-trimethoxyquinazolines Cpds. of formula (I) (where Y, Y1 and Y2 are 1-3C alkoxy and R and R1 are H, 1-4C alkyl or a group -CH2(CH2)nONO2 (a), -CH2(CH2R2)nONO2 (b) or -CH2(CH2)zN CH2(CH2)zONO2 2 (c) in which R2 is -(CH2)mCH3 or -(CH2)yONO2, n is 1-6, m is 0-4 (7+n is not >6) y is 1-4 (n+y is not >7) and z is 1-4, at least one and not more than two nitrate groups being present and one of R and R1 being H or alkyl when the other is a group (b), or NRR1 is a residue and corr. cpds. in which -ONO2 residues are replaced by OH, have hypotensive and coronary dilating activity, some also have antiarrhythmic activity.
Description
Die Erfindung betrifft ein Verfahren zur Herstellung von 6,7,84rialkoxychinazolin-4+3H) onen der Formel I,
EMI1.1
worin Y, Y, und Y2 gleich oder verschieden sein können und jeweils Aikoxy mit 1-3 Kohlenstoffatomen bedeuten.
Das erfindungsgemässe Verfahren ist dadurch gekennzeichnet, dass man Verbindungen der Formel II,
EMI1.2
worin Y, Y1 und Y2 obige Bedeutung besitzen, mit Formamid kondensiert.
Das Verfahren wird in an sich bekannter Weise durchgeführt, beispielsweise bei Rückflusstemperatur des Reaktionsgemisches.
Die Verbindungen der Formel II sind bekannt oder in an sich bekannter Weise herstellbar. Zu ihnen kann man beispielsweise gelangen, indem man Verbindungen der formel III,
EMI1.3
worin Y, Y, und Y2 obige Bedeutung haben, reduziert.
Das Verfahren kann in herkömmlicher Weise durchgeführt werden, beispielsweise durch katalytische Hydrierung, z.B. mittels eines 'Palladium¯Kohle Katalysators.
Die Verbindungen der Formel III sind bekannt oder in an sich bekannter Weise herstellbar.
Die Verbindungen der Formel I stellen Zwischenprodukte 'dar und können beispielsweise zur Herstellung wertvoller Pharmazeutika verwendet werden.
Beispiel 6,7,8-Trimethoxychinazolin-4(3H)-on a) 2-Amino-3,4,5-trimethoxymethylbenzoat
Ein Gemisch aus 39 g 2-Nitro-3,4,5-trimethoxymethyl- benzoat, 100 ml Essigsäure und 2,5 g 5% Palladium auf Kohle wird bei einer Temperatur von 600 C 25 Stunden mit Wasserstoff unter einem Druck von 3,5 kg/cm2 geschüttelt. Sodann wird abfiltriert und im Vakuum eingeengt. Der erhaltene Rückstand wird zwischen Methylenchlorid und einem Überschuss an Natriumcarbonat Lösung aufgeteilt. Die Methylenchlorid-Lösung wird getrocknet und im Vakuum eingeengt, und nach Destillation des hierbei erhaltenen Öls (105 C, 5 X 10-3 mm) gelangt man zu einem Öl von 2Amino-3,4,5-trimethoxyme- thylbenzoat.
b) 6,7,8-TrFrnethoxShiruzolin-4(3H)-on
Eine Lösung von 24,2 g 2-Amino-3,4,5-Trimethoxy- methylbenzoat in 80 ml 99%igem Formamid wird 1,25 Stunden zum kückfluss erhitzt. Man kühlt das Reaktionsgemisch ab, versetzt es mit 200 ml Eiswasser, filtriert den Feststoff ab, wäscht mit Wasser und trocknet, wobei man zum 6,7,8-Trimethoxychinazolin-4(3H)on vom Smp. 2202220C gelangt.
PATENTA0NSPRUCH
Verfahren zur Herstellung von 6,7,8-Trialkoxychin azolin-4(3H)onen der Formel I,
EMI1.4
worin Y, Y1 und Y2 gleich oder verschieden sein können und jeweils Alkoxy mit 1-3 Kohlenstoffatomen bedeuten, dadurch gekennzeichnet, dass man Verbindungen der Formel II,
EMI1.5
worin Y, Y1 und Y obige Bedeutung besitzen, mit Formamid kondensiert.
**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.
The invention relates to a process for the preparation of 6,7,84rialkoxyquinazolin-4 + 3H) ones of the formula I,
EMI1.1
where Y, Y and Y2 can be identical or different and each represent alkoxy having 1-3 carbon atoms.
The inventive method is characterized in that compounds of the formula II,
EMI1.2
wherein Y, Y1 and Y2 have the above meanings, condensed with formamide.
The process is carried out in a manner known per se, for example at the reflux temperature of the reaction mixture.
The compounds of the formula II are known or can be prepared in a manner known per se. You can get to them, for example, by using compounds of formula III,
EMI1.3
where Y, Y, and Y2 have the above meanings, reduced.
The process can be carried out in a conventional manner, for example by catalytic hydrogenation, e.g. using a palladium carbon catalyst.
The compounds of the formula III are known or can be prepared in a manner known per se.
The compounds of the formula I represent intermediates and can be used, for example, for the production of valuable pharmaceuticals.
Example 6,7,8-Trimethoxyquinazolin-4 (3H) -one a) 2-Amino-3,4,5-trimethoxymethylbenzoate
A mixture of 39 g of 2-nitro-3,4,5-trimethoxymethyl benzoate, 100 ml of acetic acid and 2.5 g of 5% palladium on carbon is treated with hydrogen at a temperature of 600 ° C. for 25 hours under a pressure of 3.5 kg / cm2 shaken. It is then filtered off and concentrated in vacuo. The residue obtained is partitioned between methylene chloride and an excess of sodium carbonate solution. The methylene chloride solution is dried and concentrated in vacuo, and after distillation of the oil obtained in this way (105 ° C., 5 × 10-3 mm), an oil of 2-amino-3,4,5-trimethoxymethyl benzoate is obtained.
b) 6,7,8-TrFrnethoxShiruzolin-4 (3H) -one
A solution of 24.2 g of 2-amino-3,4,5-trimethoxymethylbenzoate in 80 ml of 99% formamide is refluxed for 1.25 hours. The reaction mixture is cooled, 200 ml of ice water are added, the solid is filtered off, washed with water and dried, giving 6,7,8-trimethoxyquinazolin-4 (3H) one with a melting point of 2202220C.
PATENT CLAIM
Process for the preparation of 6,7,8-trialkoxyquin azolin-4 (3H) ones of the formula I,
EMI1.4
in which Y, Y1 and Y2 can be identical or different and are each alkoxy with 1-3 carbon atoms, characterized in that compounds of the formula II,
EMI1.5
wherein Y, Y1 and Y have the above meanings, condensed with formamide.
** WARNING ** End of DESC field could overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87043969A | 1969-12-05 | 1969-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH545296A true CH545296A (en) | 1974-01-31 |
Family
ID=25355372
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1519273A CH554878A (en) | 1969-12-05 | 1970-11-23 | Process for the preparation of 6,7,8-TRIALCOXYCHINAZOLINES SUBSTITUTED IN POSITION 4. |
CH1519573A CH545296A (en) | 1969-12-05 | 1970-11-23 | 4-amino-6,7,8-trimethoxyquinazolines |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1519273A CH554878A (en) | 1969-12-05 | 1970-11-23 | Process for the preparation of 6,7,8-TRIALCOXYCHINAZOLINES SUBSTITUTED IN POSITION 4. |
Country Status (8)
Country | Link |
---|---|
AT (1) | AT317218B (en) |
CH (2) | CH554878A (en) |
DK (2) | DK126329B (en) |
NO (1) | NO130477C (en) |
PL (1) | PL77821B1 (en) |
RO (1) | RO60107A (en) |
SU (1) | SU400098A3 (en) |
ZA (1) | ZA708200B (en) |
-
1970
- 1970-08-28 DK DK444470AA patent/DK126329B/en unknown
- 1970-08-28 NO NO3285/70A patent/NO130477C/no unknown
- 1970-11-23 CH CH1519273A patent/CH554878A/en not_active IP Right Cessation
- 1970-11-23 CH CH1519573A patent/CH545296A/en not_active IP Right Cessation
- 1970-12-03 RO RO65179A patent/RO60107A/ro unknown
- 1970-12-03 PL PL1970150248A patent/PL77821B1/en unknown
- 1970-12-04 AT AT1094670A patent/AT317218B/en not_active IP Right Cessation
- 1970-12-04 SU SU1499660A patent/SU400098A3/ru active
- 1970-12-04 ZA ZA708200A patent/ZA708200B/en unknown
-
1971
- 1971-08-11 DK DK392471AA patent/DK125799B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO130477C (en) | 1974-12-18 |
DK126329B (en) | 1973-07-02 |
ZA708200B (en) | 1972-07-26 |
PL77821B1 (en) | 1975-04-30 |
SU400098A3 (en) | 1973-10-03 |
AT317218B (en) | 1974-08-26 |
CH554878A (en) | 1974-10-15 |
NO130477B (en) | 1974-09-09 |
RO60107A (en) | 1976-08-15 |
DK125799B (en) | 1973-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0070397B1 (en) | Process and catalyst for the preparation of cyclic imines | |
CH545296A (en) | 4-amino-6,7,8-trimethoxyquinazolines | |
DE2329545C2 (en) | 1,2-bis-oxazolinyl- (2) -cyclobutanes and processes for their preparation | |
DE1052983B (en) | Process for the production of cyclohexanone | |
DE1277244B (en) | Process for the preparation of 2,3-dibromobutene- (2) -diol- (1,4), 2,2,3,3-tetrabromobutanediol- (1,4) and / or mucobromic acid | |
AT352097B (en) | PROCESS FOR THE PRODUCTION OF CYANIUM FORMAMIDE FROM HYDROGEN CYANE AND OXYGEN | |
DE819692C (en) | Process for the preparation of 4-amino-2,6-dialkyl- or -diaralkylpyrimidines | |
DE2161995C3 (en) | Process for the preparation of benzotrifluoride or its derivatives | |
AT288363B (en) | Process for the preparation of new β-aroyl-β-haloacrylic acids | |
CH551982A (en) | 4-amino-6,7,8-trimethoxyquinazolines | |
DE1168413B (en) | Process for the preparation of monomethyl ester monoamides of carbocyclic, aromatic dicarboxylic acids | |
AT375343B (en) | METHOD FOR PRODUCING THE NEW 1-METHYL-5 (P-TOLUOYL) -3-CARBOXYPYRROL-2-ACETIC ACID | |
DE2139084B2 (en) | Process for the preparation of 4,4-diphenyl-piperidines | |
AT272332B (en) | Process for the production of coumarin | |
AT211322B (en) | Process for the preparation of substituted tetrahydro-oxazines | |
DE1445895C (en) | Process for the preparation of 2 dehydroemetine derivatives | |
AT233018B (en) | Process for the preparation of new iminodibenzyl derivatives | |
DE823292C (en) | Process for the partial hydrogenation of unsaturated organic compounds | |
DE3429439A1 (en) | METHOD FOR PRODUCING PANTOLACTONE | |
AT226238B (en) | Process for the production of ω-ureidocarboxylic acids | |
AT273967B (en) | Process for the preparation of new salts of substituted s-triazines | |
AT247339B (en) | Process for the production of new quinazolone compounds | |
AT200572B (en) | Process for the production of aromatic di- and polycarboxylic acids | |
DE949652C (en) | Process for the rearrangement of naphthalic acid into naphthalene-2,6-dicarboxylic acid | |
AT225173B (en) | Process for the preparation of α, β- δ, ε-unsaturated carboxylic acid esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |